1. Home
  2. PCRX vs CCRN Comparison

PCRX vs CCRN Comparison

Compare PCRX & CCRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • CCRN
  • Stock Information
  • Founded
  • PCRX 2006
  • CCRN 1986
  • Country
  • PCRX United States
  • CCRN United States
  • Employees
  • PCRX N/A
  • CCRN N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • CCRN Professional Services
  • Sector
  • PCRX Health Care
  • CCRN Consumer Discretionary
  • Exchange
  • PCRX Nasdaq
  • CCRN Nasdaq
  • Market Cap
  • PCRX 1.2B
  • CCRN 587.1M
  • IPO Year
  • PCRX 2011
  • CCRN N/A
  • Fundamental
  • Price
  • PCRX $26.59
  • CCRN $18.19
  • Analyst Decision
  • PCRX Buy
  • CCRN Buy
  • Analyst Count
  • PCRX 10
  • CCRN 3
  • Target Price
  • PCRX $29.30
  • CCRN $18.31
  • AVG Volume (30 Days)
  • PCRX 892.8K
  • CCRN 431.7K
  • Earning Date
  • PCRX 02-27-2025
  • CCRN 02-19-2025
  • Dividend Yield
  • PCRX N/A
  • CCRN N/A
  • EPS Growth
  • PCRX N/A
  • CCRN N/A
  • EPS
  • PCRX N/A
  • CCRN N/A
  • Revenue
  • PCRX $694,957,000.00
  • CCRN $1,448,099,000.00
  • Revenue This Year
  • PCRX $5.14
  • CCRN N/A
  • Revenue Next Year
  • PCRX $2.44
  • CCRN N/A
  • P/E Ratio
  • PCRX N/A
  • CCRN N/A
  • Revenue Growth
  • PCRX 4.40
  • CCRN N/A
  • 52 Week Low
  • PCRX $11.16
  • CCRN $9.58
  • 52 Week High
  • PCRX $31.67
  • CCRN $21.41
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 77.75
  • CCRN 71.82
  • Support Level
  • PCRX $25.06
  • CCRN $18.17
  • Resistance Level
  • PCRX $27.10
  • CCRN $18.26
  • Average True Range (ATR)
  • PCRX 1.45
  • CCRN 0.06
  • MACD
  • PCRX 0.28
  • CCRN -0.13
  • Stochastic Oscillator
  • PCRX 86.23
  • CCRN 50.00

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

Share on Social Networks: